Haleon plc (HLN) Financial Statements

Executive TeamFinancials
Shareholders

Haleon financial statements at a glance

Haleon reported revenue of 11.03 billion GBP for fiscal year 2025 (ended December 31, 2025), down 1.8% from fiscal year 2024. Net income was 1.67 billion GBP, a net margin of 15.1%, and diluted earnings per share were 0.37 GBP.

At the end of fiscal year 2025 it had total assets of 32.63 billion GBP, total liabilities of 16.15 billion GBP and shareholders' equity of 16.43 billion GBP, with cash and short-term investments of 1.26 billion GBP and total debt of 8.58 billion GBP.

Its operations brought in 2.63 billion GBP of cash; capital spending was 413.00 million GBP, leaving free cash flow of 2.22 billion GBP.

The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.

Figures from company filings, in GBP; latest fiscal year ended December 31, 2025.

HLN logo

Haleon plc

HLNUnited Kingdom
Healthcare
GBP (Local)

Income Statement

Annual • GBP

Total Revenue
11.03B
Prev Year: 11.23B
YoY: -1.8%
Operating Revenue
11.03B
Prev Year: 11.23B
YoY: -1.8%
Total Unusual Items
45.00M
Prev Year: 43.00M
YoY: +4.7%
Normalized EBITDA
2.81B
Prev Year: 2.58B
YoY: +8.9%
Tax Rate for Calcs
0.219
Prev Year: 0
Tax Effect of Unusual Items
9.87M
Prev Year: 9.79M
YoY: +0.8%
Total Operating Income as Reported
2.41B
Prev Year: 2.21B
YoY: +9.3%
Special Income Charges
52.00M
Prev Year: -7.00M
YoY: +842.9%
Other Special Charges
-52.00M
Prev Year: 7.00M
YoY: -842.9%
Total Other Finance Cost
15.00M
Prev Year: 10.00M
YoY: +50.0%
Cost of Revenue
3.95B
Prev Year: 4.41B
YoY: -10.4%
Gross Profit
7.08B
Prev Year: 6.82B
YoY: +3.8%
Operating Expense
4.67B
Prev Year: 4.62B
YoY: +1.1%
Selling General and Administrative
4.36B
Prev Year: 4.45B
YoY: -2.0%
General and Administrative Expense
4.36B
Prev Year: 4.45B
YoY: -2.0%
Research and Development
316.00M
Prev Year: 298.00M
YoY: +6.0%
Other Operating Expenses
-12.00M
Prev Year: -132.00M
YoY: +90.9%
Operating Income
2.41B
Prev Year: 2.21B
YoY: +9.3%
Net Non Operating Interest Income Expense
-305.00M
Prev Year: -339.00M
YoY: +10.0%
Non-operating Interest Income
57.00M
Prev Year: 65.00M
YoY: -12.3%
Non-operating Interest Expense
347.00M
Prev Year: 394.00M
YoY: -11.9%
Pre-tax Income
2.15B
Prev Year: 1.91B
YoY: +12.7%
Other Income Expense
-
Provision for Income Taxes
472.00M
Prev Year: 435.00M
YoY: +8.5%
Net Income Common Stockholders
1.67B
Prev Year: 1.44B
YoY: +15.6%
Net Income
1.67B
Prev Year: 1.44B
YoY: +15.6%
Net Income Including Non-Controlling Interests
1.68B
Prev Year: 1.48B
YoY: +13.9%
Net Income from Continuing Operations
1.68B
Prev Year: 1.48B
YoY: +13.9%
Noncontrolling Interests
-13.00M
Prev Year: -33.00M
YoY: +60.6%
Diluted NI Available to Com Stockholders
1.67B
Prev Year: 1.44B
YoY: +15.6%
Basic EPS
0.372
Prev Year: 0.32
YoY: +16.2%
Diluted EPS
0.37
Prev Year: 0.31
YoY: +19.4%
Weighted Average Shares (basic)
4.49B
Prev Year: 4.57B
YoY: -1.6%
Weighted Average Shares (diluted)
4.51B
Prev Year: 4.59B
YoY: -1.6%
Total Expenses
8.62B
Prev Year: 9.03B
YoY: -4.5%
Net Income from Continuing and Discontinued Operation
1.67B
Prev Year: 1.44B
YoY: +15.6%
Normalized Income
1.63B
Prev Year: 1.41B
YoY: +15.8%
Interest Income
57.00M
Prev Year: 65.00M
YoY: -12.3%
Interest Expense
347.00M
Prev Year: 394.00M
YoY: -11.9%
Net Interest Income
-305.00M
Prev Year: -339.00M
YoY: +10.0%
EBIT
2.50B
Prev Year: 2.30B
YoY: +8.5%
EBITDA
2.86B
Prev Year: 2.63B
YoY: +8.8%
Reconciled Cost of Revenue
3.95B
Prev Year: 4.41B
YoY: -10.4%
Reconciled Depreciation
360.00M
Prev Year: 324.00M
YoY: +11.1%
Net Income from Continuing Operation Net Minority Interest
1.67B
Prev Year: 1.44B
YoY: +15.6%
Total Unusual Items Excluding Goodwill
45.00M
Prev Year: 43.00M
YoY: +4.7%
Values in GBP

Haleon key figures by fiscal year

FY2025FY2024FY2023FY2022FY2021
Revenue11.0B GBP11.2B GBP11.3B GBP10.9B GBP9.5B GBP
Gross profit7.1B GBP6.8B GBP6.7B GBP6.6B GBP6.0B GBP
Operating income2.4B GBP2.2B GBP2.0B GBP1.8B GBP1.6B GBP
Net income1.7B GBP1.4B GBP1.0B GBP1.1B GBP1.4B GBP
Diluted EPS0.37 GBP0.31 GBP0.23 GBP0.23 GBP0.30 GBP
Total assets32.6B GBP34.3B GBP34.1B GBP34.8B GBP34.5B GBP
Total liabilities16.1B GBP18.1B GBP17.3B GBP18.4B GBP8.0B GBP
Shareholders' equity16.4B GBP16.2B GBP16.6B GBP16.3B GBP26.4B GBP
Cash and short-term investments1.3B GBP2.2B GBP994.0M GBP606.0M GBP347.0M GBP
Total debt8.6B GBP10.1B GBP9.4B GBP10.4B GBP991.0M GBP
Operating cash flow2.6B GBP2.3B GBP2.1B GBP2.1B GBP1.4B GBP
Capital spending413.0M GBP318.0M GBP336.0M GBP328.0M GBP298.0M GBP
Free cash flow2.2B GBP2.0B GBP1.8B GBP1.7B GBP1.1B GBP

In GBP. Fiscal years as reported by the company; statements on this page go back to fiscal year 2019.

Questions and answers

What was Haleon's revenue in fiscal year 2025?

11.03 billion GBP, down 1.8% from 11.23 billion GBP in fiscal year 2024.

How much profit does Haleon make?

Haleon reported net income of 1.67 billion GBP for fiscal year 2025 (15.1% of revenue); operating income was 2.41 billion GBP.

How much cash and debt does Haleon have?

At the end of fiscal year 2025: cash and short-term investments of 1.26 billion GBP and total debt of 8.58 billion GBP.

What is Haleon's free cash flow?

2.22 billion GBP in fiscal year 2025 (operating cash flow of 2.63 billion GBP minus capital spending of 413.00 million GBP).

MoreHaleon stock overviewHaleon executive teamHaleon shareholders
RelatedPharmaceutical Preparation Manufacturing industryManufacturing sectorGSK financialsTakeda Pharmaceutical financialsTeva Pharmaceutical Industries financialsRoyalty Pharma financialsViatris financialsDr. Reddy's Laboratories financials
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
© 2026 DataPorium. All rights reserved.|About & MethodologyPrivacy PolicyTerms of Use
LinkedInLinkedInXXYouTubeYouTube